Company Overview and News
Orinoco Gold Ltd (ASX:OGX) is continuing to make steady progress on recommissioning operations at its Cascavel Mine, a core asset within its Faina Goldfields Project in Brazil.
Junior miner Orinoco Gold has announced a $12.1 million capital raising to target a ramp up in production at its Cascavel operation in Brazil.
Mendy Amzalak of AMZ Capital has narrowed the gap with race leader Angie Ellis of 80 20 Investments, in week three of the four-week shares race.
Angie Ellis of 80 20 Investments has maintained her lead over her closest rival, Mendy Amzalak of AMZ Capital, in week two of the four-week shares race with her original $100,000 portfolio worth $114,584.
Tyranna Resources Ltd (ASX:TYX) non-executive director Joseph Pinto has demonstrated his confidence in the company’s gold strategy by increasing his indirect interest.
Tyranna Resources Ltd (ASX:TYX) has set the scene for a busy 2018 work program across its portfolio of gold projects while its gold investments are increasing in value.
Shares in Orinoco Gold and Doray Minerals have enjoyed price rises today after announcing positive drilling results at their respective projects.
Orinoco has cited the benefits of its back-to-basics approach to milling at its Cascavel gold mine in Brazil, returning six samples from its pilot hammer mill with an average grade of 36.68 grams per tonne (g/t) of gold.
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO UNITED STATES SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.
Tyranna Resources Ltd (ASX:TYX) is commencing a diamond drilling program at the Greenwood Gold Prospect, part of the larger Jumbuck Gold Project in South Australia.
Tyranna Resources Ltd (ASX:TYX) continues to benefit from investor demand for companies exploring for conglomerate-hosted gold in the Pilbara region of Western Australia.
Orinoco Gold Ltd (ASX:OGX) shares closed 31% higher today after continuing to make significant progress on its plan to re-commence operations at the Cascavel Gold Mine in Brazil.
Nuheara Ltd (ASX:NUH) rose 4% to $0.096 after American retailer Brookstone said it would stock the company’s breakthrough earbuds in a further 150 stores. This means the product, which includes dynamic noise control and speech amplification, is available in 201 outlets. Chief executive Justin Miller said the expansion of the existing agreement underscored the “vast sales potential” of its IQbuds brand.
Orinoco Gold (ASX:OGX) has now confirmed the appointment of Craig Dawson as the company's chief executive officer, effective from 1 June 2017.
Perth explorer Orinoco Gold has announced plans to buy out its joint venture partners at the Cascavel mine for $US6.3 million in cash and shares, while both its managing director and chairman have tendered their resignation.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...